Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
12/2008
12/11/2008US20080306065 Metalloproteinase Inhibitors
12/11/2008US20080306060 Fused Thiazole Derivatives as Kinase Inhibitors
12/11/2008US20080306056 PYRAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
12/11/2008US20080306055 Heterocyclic Mchr1 Antagonists And Their Use In Therapy
12/11/2008US20080306052 e.g.1-{3-[5-(4-chlorophenyl)-2-oxo-6H-1,3,4-thiadiazin-3-ylmethyl]phenyl}-3-(1-methylpyrrolidin-3-ylmethyl)urea; inhibitors of tyrosine kinases, in particular Met kinase; antitumor, antiinflammatory agent
12/11/2008US20080306041 Cardiovascular Compounds Comprising Heterocyclic Nitric Oxide Donor Groups, Compositions and Methods of Use
12/11/2008CA2689514A1 Heterobicyclic compounds as kinase inhibitors
12/10/2008EP2000465A1 Triazolone derivative
12/10/2008EP1999128A1 Tetomilast polymorphs
12/10/2008EP1999120A1 Benzothiazoles having histamine h3 receptor activity
12/10/2008EP1999119A2 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
12/10/2008EP1999114A2 Pyrazoles as 11-beta-hsd-1
12/10/2008EP1673085A4 C-met modulators and methods of use
12/10/2008EP1638958A4 Zwitterionic non-linear optophores and devices incorporating same
12/10/2008EP1396487B1 Phenylpyridine carbonyl piperazine derivative
12/10/2008EP1094816B1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/10/2008CN101321766A Substituted benzofused derivatives and their use as vanilloid receptor ligands
12/10/2008CN101321747A Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase
12/10/2008CN101321743A L , l , 3-tri0x0-l , 2 , 5-thiadiaz0lidines and their use as PTP-ases inhibitors
12/10/2008CN101318957A Substituted thiazolidinedione derivative, process for its preparation and its pharmaceutical use
12/10/2008CN101318956A Substituted thiazolidinedione derivative, process for its preparation and its pharmaceutical use
12/10/2008CN100441571C Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors
12/10/2008CN100441185C 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors
12/10/2008CN100441182C Nociceptin analogs
12/09/2008US7462723 e.g. N1-[(E)-1-(4-fluorophenyl)methylidene]-4-(1,3-thiazol-2-yl)-1H-1,2-imidazolediamine; anticarcinogenic agent; sid effect reduction
12/09/2008US7462636 Broadspectrum substituted benzisoxazole sulfonamide HIV protease inhibitors
12/09/2008US7462634 N-(pyridin-2-yl)-sulfonamide derivatives
12/09/2008US7462633 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
12/09/2008US7462630 Diarylalkene derivatives and novel diarylalkane derivatives
12/09/2008US7462625 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
12/09/2008CA2379061C Antibacterial agents
12/04/2008WO2008147941A1 Processes for making epothilone compounds and analogs
12/04/2008WO2008147697A1 Benzimidazolone chymase inhibitors
12/04/2008WO2008147626A2 Thiazoles and pyrazoles useful as kinase inhibitors
12/04/2008WO2008147557A2 Heteroaryl substituted thiazoles and their use as antiviral agents
12/04/2008WO2008147518A1 Pyridyl piperidine orexin receptor antagonists
12/04/2008WO2008146774A1 Tetrahydroisoquinolin-1-one derivative or salt thereof
12/04/2008WO2008146172A2 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
12/04/2008WO2008145596A1 Piperidine-amide derivatives
12/04/2008WO2008145243A1 Pyridazinone derivatives
12/04/2008WO2008126024A3 Oxazolidinone antibiotic derivatives
12/04/2008WO2008115973A3 Aminopyrimidines useful as kinase inhibitors
12/04/2008WO2008094992A3 2-aminopyridine derivatives useful as kinase inhibitors
12/04/2008WO2008062905A3 Heteromonocyclic compound and use thereof
12/04/2008WO2007146122A3 Tetrahydropyrido[3,4-d]pyrimidines and related analogues
12/04/2008WO2007127440A3 Heterofunctional poly(ethylene glycol) containing acid-labile amino protecting groups and uses thereof
12/04/2008US20080300407 Pyridinoylpiperidines as 5-HT1F agonists
12/04/2008US20080300285 Chemical Compounds
12/04/2008US20080300282 Coupling thiazolidine-2,4-dione with p-(2-alkylpyridyl-2-hydroxy-, Cl-, Br-, mesyl- or tosyl-ethoxybenzaldehyde in a solvent, an organic base and an organic acid catalyst and hydrogenating the product to form 5-[4-[2-(alkylpyridyl)2-hydroxy-, Cl-, Br-, mesyl- or tosylethoxy]benzyl-2,4-thiazolidinedione
12/04/2008US20080300275 Novel Benzothiazolone Derivatives
12/04/2008US20080300266 metabotropic glutamate receptor (mGluR3) antagonists such as [1-(5-bromopyrimidin-2-yl)-pyrrolidin-3-yl]-(2,4-dichlorobenzyl)-amine, used for the treatment of depression, schizophrenia and headaches
12/04/2008US20080300249 tyrosine kinase inhibitors such as 5-(3,3-Dimethyl-ureido)-3-heptyloxy-isothiazole-4-carboxylic acid amide, used for treating hyperproliferative disorders in mammals; anticarcinogenic agents; antiproliferative agents
12/04/2008US20080300234 N-(1-Methyl-1-phenyl-ethyl)-3-{[2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-5-trifluoromethyl-pyrimidin-4-ylamino]-methyl}-benzenesulfonamide, useful in the treatment of breast cancer
12/04/2008US20080300232 N-Piperidine Derivatives as Ccr3 Modulators
12/04/2008US20080299639 adduct comprising a molecule binding with a kinase; antiinflammatory agents; modulating activation state of p38 kinase protein; switch control ligands to induce or restrict conformation
12/04/2008US20080299593 Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
12/04/2008DE102007025718A1 Pyridazinonderivate Pyridazinone derivatives
12/04/2008CA2689383A1 Piperidine-amide derivatives
12/04/2008CA2688599A1 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
12/04/2008CA2688518A1 Pyridazinone derivatives for use in the treatment of a disease which is influenced by inhibiton of met kinase
12/04/2008CA2688326A1 Tetrahydroisoquinolin-1-one derivative or salt thereof
12/04/2008CA2687966A1 Thiazoles and pyrazoles useful as kinase inhibitors
12/04/2008CA2687821A1 Benzimidazolone chymase inhibitors
12/04/2008CA2687817A1 Heteroaryl substituted thiazoles
12/04/2008CA2687321A1 Pyridyl piperidine orexin receptor antagonists
12/03/2008EP1997856A1 Optical recording medium and azo metal chelate compound
12/03/2008EP1997818A2 Quinolinone derivatives and their use to treat pain
12/03/2008EP1997813A1 Substituted isoxazoline compound and pest control agent
12/03/2008EP1997805A1 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
12/03/2008EP1996583A1 Thiazoles as nf-kb inhibitors (proteasome inhibitors)
12/03/2008EP1996578A1 Heterobicyclic carboxamides as inhibitors for kinases
12/03/2008EP1996576A1 Ccr5 antagonists useful for treating hiv
12/03/2008EP1996574A1 Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors
12/03/2008EP1996567A2 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
12/03/2008EP1996566A1 Bezothiazol derivatives as beta2 adrenoreceptor agonists
12/03/2008EP1996565A2 Substituted aminothiazole derivatives with anti-hcv activity
12/03/2008EP1996563A1 Heterobicyclic sulfonamide derivatives for the treatment of diabetes
12/03/2008EP1996562A1 Substituted 4-amino-quinazoline derivatives as regulators of metabotropic glutamate receptors and their use for producing drugs
12/03/2008EP1996558A1 Heterobicyclic carboxamides as inhibitors for kinases
12/03/2008EP1996555A1 Compounds which potentiate ampa receptor and uses thereof in medicine
12/03/2008EP1996546A2 Substituted gamma lactams as prostaglandin ep2 agonists
12/03/2008EP1996202A1 Chemical compounds
12/03/2008EP1737463B1 Pyrimidines with tie2 (tek) activity
12/03/2008EP1492785B1 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
12/03/2008EP1480954B1 Vanilloid receptor modulators
12/03/2008EP1426371B1 Tetrazoyl oxime derivatives and agrochemicals containing the same as the active ingredient
12/03/2008EP1250337B1 Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
12/03/2008EP1068202B1 1-(3-heteroarylpropyl- or -prop-2-enyl)-4-benzylpiperidines used as nmda receptor antagonists
12/03/2008CN101316844A Inhibitors of diacylglycerol acyltransferase (DGAT)
12/03/2008CN101316837A Substituted pyrrolones as allosteric modulators of glucokinase
12/03/2008CN101316836A Substituted dihydroisoindolones as allosteric modulators of glucokinase
12/03/2008CN101314600A Antineoplastic compound, medicament composition and use thereof
12/03/2008CN101314599A Method for preparation of thiamine dilauryl sulfate
12/03/2008CN100440045C Polymeric charge transport compositions for organophotoreceptors
12/03/2008CN100439374C Epothilone derivatives
12/03/2008CN100439351C Benzofuran derivative
12/03/2008CN100439340C 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
12/03/2008CN100439337C Phenyl substituted piperidine compounds for use as PPAR activators
12/02/2008US7459562 Monocyclic heterocycles as kinase inhibitors
12/02/2008US7459561 Containing pyridine, phenyl, thiazole and triazole rings, e.g., 1-[[N-methyl-N-3-[(methylamino)acetoxymethyl]pyridin-2-yl]carbamoyloxy]ethyl-1-[(2R,3R)-2-(2,4-difluorophenyl)-2-hydroxy-3-[4-(4-cyanophenyl)thiazol-2-yl ]butyl]-1H-[1,2,4]triazol-4-ium chloride; parenteral treatment of fungal diseases